glp-1 drugs what is it Agonists: A Comprehensive Overview GLP-1 Receptor Agonist Market Size

DPP-4 deactivates incretin hormones such as glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP), producing inactive metabolites GLP-1(936) amide and GIP (342) [49]

Oral semaglutide, which is used for metabolic health and weight management, must be taken on an empty stomach with a small amount of water, followed by a 30-minute wait before eating or drinking anything else

There are also possible side effects such as nausea, vomiting, diarrhea and constipation

Promotional value is best judged by longterm utility

Diabetes Obes Metab (2022) 24 Suppl 1:1726

Abstract Type 2 diabetes mellitus (T2DM) is a chronic progressive metabolic disease that has become a growing health problem worldwide, and the dangers of hyperglycemia and its chronic complications have long been considered a goal of diabetes treatment